ENVX on Nasdaq
Enovix Corporation
Logo: enovix.com4
Battery technology company1
In its 2026 annual report the company says: “Enovix Corporation is a global high-performance battery company focused on designing, developing, manufacturing, and commercializing advanced Lithium-ion, or Li-ion, batteries, including proprietary silicon-anode architectures, for smartphones, smart eyewear, defense, industrial and emerging edge-AI applications. Our proprietary silicon-anode battery architecture enables higher energy density and performance relative to conventional battery cells, particularly in space-constrained devices.”7 It is headquartered in Wilmington, United States.1 Its shares trade on Nasdaq under the symbol ENVX.1
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with Beam Global, PIONEER POWER SOLUTIONS, INC. or XCHG Ltd, or pick any stock.
- TickerENVX on Nasdaq1
- IndustryMiscellaneous Electrical Machinery, Equipment & Supplies1
- HeadquartersWilmington, United States1
- Websitewww.enovix.com
- Business address3501 W. Warren Avenue, Fremont, Ca 945385
- Filer categoryLarge accelerated filer5
- Legal formCorporation3
- LEI549300EC7NZGWORHYJ533
- StatusActive3
- LEI statusIssued and current3
- Registered address1521 CONCORD PIKE SUITE 201, 19803 Wilmington, United States3
- Registered withDivision of Corporations, Department of State, 37270203
See how the biggest companies compare on our leaderboards
Enovix Corporation (the “Company,” “we,” “us,” “our” and “Enovix”) is a global high-performance battery company focused on designing, developing, manufacturing, and commercializing advanced Lithium-ion, or Li-ion, batteries, including proprietary silicon-anode architectures, for smartphones, smart eyewear, defense, industrial and emerging edge-AI applications. Our proprietary silicon-anode battery architecture enables higher energy density and performance relative to conventional battery cells, particularly in space-constrained devices. Our battery’s mechanical design, or “architecture,” allows us to use high performance chemistries while maintaining safety and reliability, supporting commercialization opportunities across various consumer and industrial markets.7 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Regions
Asia Pacific brought in 68% of the revenue Enovix Corporation broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| Asia Pacific | $5.9M | $12.9M | $21.6M |
| Switzerland | $0 | $4.8M | $4.3M |
| United States | $473.0K | $889.0K | $2.1M |
| NO | $0 | $2.4M | $1.5M |
| Other | $1.1M | $1.3M | $1.2M |
| Taiwan | $193.0K | $889.0K | $1.0M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue12¢$25.7M
- Research and development52¢$110.3M
- Selling, general and admin35¢$73.0M
- Income tax1¢$1.3M
Out of $31.8M in revenue.8 The company lost money this year.
Financial statements
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $09 | $010 | $7.6M8 | $23.1M8 | $31.8M8 | ||
| Cost of revenue | $3.4M9 | $2.0M10 | $63.1M8 | $25.1M8 | $25.7M8 | ||
| Gross profit | -$3.4M9 | -$2.0M10 | -$55.4M8 | -$2.0M8 | $6.1M8 | ||
| Research and development | $14.4M9 | $37.9M10 | $88.4M8 | $124.5M8 | $110.3M8 | ||
| Selling, general and admin | $5.7M9 | $29.7M10 | $79.0M8 | $74.3M8 | $73.0M8 | ||
| Operating expenses | $67.6M10 | $174.8M8 | $240.6M8 | $183.4M8 | |||
| Operating income | -$23.5M9 | -$69.5M10 | -$230.3M8 | -$242.7M8 | -$177.3M8 | ||
| Interest | $187.0K10 | $4.5M10 | |||||
| Income before tax | -$125.9M10 | -$214.8M8 | -$223.9M8 | -$157.9M8 | |||
| Income tax | $09 | $010 | -$633.0K8 | -$1.4M8 | -$1.3M8 | ||
| Net income | -$39.6M9 | -$125.9M10 | -$214.1M8 | -$222.2M8 | -$156.7M8 | ||
| Earnings per share | -$0.499 | -$1.0710 | -$1.278 | -$1.198 | -$0.758 | ||
| Earnings per share (diluted) | -$0.499 | -$1.0710 | -$1.308 | -$1.198 | -$0.758 | ||
| Shares (weighted, basic) | 117.2M shares10 | 169.1M shares8 | 186.0M shares8 | 207.6M shares8 | |||
| Shares (weighted, diluted) | 117.2M shares10 | 169.6M shares8 | 186.0M shares8 | 207.6M shares8 |
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash | $10.3M9 | $29.1M9 | $385.3M10 | $233.1M8 | $272.9M8 | $106.0M8 | |
| Receivables | $09 | $909.0K14 | $4.6M8 | $4.4M8 | |||
| Inventory | $09 | $8.7M14 | $7.7M8 | $13.6M8 | |||
| Current assets | $33.0M13 | $398.1M9 | $323.2M14 | $295.0M8 | $542.2M8 | ||
| Property, plant and equipment | $76.6M9 | $166.5M14 | $167.9M8 | $170.3M8 | |||
| Goodwill | $12.1M14 | $12.2M8 | $12.2M8 | ||||
| Intangible assets | $42.2M14 | $36.4M8 | $31.6M8 | ||||
| Total assets | $65.0M13 | $482.6M9 | $564.3M14 | $527.2M8 | $879.0M8 | ||
| Accounts payable | $3.1M9 | $21.3M14 | $9.5M8 | $17.8M8 | |||
| Short-term debt | $1.6M14 | $170.0K8 | $230.0K8 | ||||
| Current liabilities | $10.9M13 | $20.6M9 | $61.0M14 | $53.7M8 | $65.0M8 | ||
| Long-term debt | $169.1M14 | $169.8M8 | $519.3M8 | ||||
| Total liabilities | $28.7M13 | $156.4M9 | $303.2M14 | $277.8M8 | $605.0M8 | ||
| Retained earnings | -$333.2M9 | -$598.8M14 | -$821.1M8 | -$977.8M8 | |||
| Shareholders’ equity | $3.0M9 | $36.2M9 | $326.1M9 | $258.1M14 | $246.7M8 | $271.2M8 | |
| Shares outstanding | 100.0M shares13 | 145.2M shares10 | 156.5M shares13 | 167.4M shares14 | 190.6M shares8 | 216.6M shares8 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -$20.1M9 | -$51.3M10 | -$104.6M8 | -$108.6M8 | -$95.3M8 | ||
| Depreciation and amortization | $1.5M10 | $34.0M8 | $45.0M8 | $35.1M8 | |||
| Stock-based compensation | $10.7M10 | $69.5M8 | $58.8M8 | $49.4M8 | |||
| Capital spending | $27.0M9 | $43.6M10 | $61.8M8 | $76.2M8 | $18.2M8 | ||
| Free cash flow | -$47.0M | -$94.9M | -$166.4M | -$184.8M | -$113.5M | ||
| Cash from investing | -$43.6M10 | -$143.0M8 | -$1.4M8 | -$538.3M8 | |||
| Share buybacks | $09 | $27.0K10 | $08 | $08 | $58.4M8 | ||
| Cash from financing | $451.1M10 | $159.6M8 | $150.7M8 | $467.4M8 |
Corporate structure
Enovix Corporation sits at the top of its group. 6 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Enovix Corporation
- BlackRock Filed SCHEDULE 13G/A on Enovix Corporation, latest Jul 28, 2026 (2 filings since Jan 29, 2024)
- VANGUARD GROUP INC Filed SCHEDULE 13G/A on Enovix Corporation, latest Mar 26, 2026 (3 filings since Feb 9, 2023)
- Thurman J. Rodgers Filed SCHEDULE 13D/A on Enovix Corporation, latest Jul 22, 2025 (2 filings since Feb 14, 2023)
- Park West Asset Management LLC Filed SC 13G/A on Enovix Corporation, latest Feb 14, 2024 (2 filings since Feb 14, 2023)
- Eclipse GP III, LLC Filed SC 13G/A on Enovix Corporation, latest Jan 25, 2023
- York Capital Management Global Advisors, LLC Filed SC 13G/A on Enovix Corporation, latest Mar 23, 2022 (2 filings since Feb 14, 2022)
- GILDER GAGNON HOWE & CO LLC Filed SC 13G/A on Enovix Corporation, latest Feb 14, 2022
- Electron Capital Partners, LLC Filed SC 13G/A on Enovix Corporation, latest Jan 11, 2022
- Enovix Corporation Wilmington, Delaware, United States
- Enovix Battery (Shenzhen) Co., Ltd. Subsidiary · China
- Enovix India Holdco LLC Subsidiary · Delaware, United States
- Enovix International Holdco LLC Subsidiary · Delaware, United States
- Enovix Malaysia Private Limited Subsidiary · Malaysia
- Enovix Research and Development Services India Private Limited Subsidiary · India
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Enovix Corporation reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $220.0M8 Dec 28, 2025 | $188.9M8 Dec 29, 2024 | +16.4% |
| Accumulated depreciation | $49.7M8 Dec 28, 2025 | $21.0M8 Dec 29, 2024 | +136.7% |
| Property and equipment, net | $170.3M8 Dec 28, 2025 | $167.9M8 Dec 29, 2024 | +1.4% |
| Operating-lease assets (leased space) | $11.7M8 Dec 28, 2025 | $13.5M8 Dec 29, 2024 | −13.3% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $106.0M8 Dec 28, 2025 | $272.9M8 Dec 29, 2024 | −61.1% |
| Marketable securities, current | $406.0M8 Dec 28, 2025 | $08 Dec 29, 2024 | |
| Debt securities available for sale | $102.6M14 Dec 29, 2024 | $138.2M14 Dec 31, 2023 | −25.8% |
| Long-term investments | $106.8M8 Dec 28, 2025 | $08 Dec 29, 2024 |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $12.2M8 Dec 28, 2025 | $12.2M8 Dec 29, 2024 | 0% |
| Intangible assets, net (excluding goodwill) | $31.6M8 Dec 28, 2025 | $36.4M8 Dec 29, 2024 | −13.1% |
| Finite-lived intangibles, net | $31.6M8 Dec 28, 2025 | $36.4M14 Dec 29, 2024 | −13.1% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $13.6M8 Dec 28, 2025 | $7.7M8 Dec 29, 2024 | +77.7% |
| Raw materials | $6.6M8 Dec 28, 2025 | $3.6M8 Dec 29, 2024 | +83.1% |
| Work in process | $6.1M8 Dec 28, 2025 | $3.0M8 Dec 29, 2024 | +103.8% |
| Finished goods | $906.0K8 Dec 28, 2025 | $1.1M8 Dec 29, 2024 | −14.4% |
Properties, in its own words
Our corporate headquarters are located in Fremont, California. The following is a summary of our principal facilities as of December 28, 2025.
Principal Operations · Location · Approximate Square Footage · Held
The rest of Item 2
Headquarters and Center for Innovation · United States · 68,600 · Leased
Manufacturing Facility · Malaysia · 278,900 · Leased
Manufacturing Facilities · South Korea · 467,400 · Owned
R&D Center · India · 18,000 · Leased
Item 2 of the 10-K filed Feb 25, 2026.7
Leadership
Who has led Enovix Corporation, and when. Pick a name to see everywhere that person has worked.
Chief financial officer
Chief operating officer
- Chief executive officerRyan A. Benton Sep 1, 2026 to now15
- Chief executive officerRajendra K. Talluri Jan 20, 2023 to Sep 1, 202616
- Chief executive officerHarrold J. Rust Jul 16, 2021 to Feb 7, 202317
- PresidentRajendra K. Talluri Jan 20, 2023 to now16
- PresidentHarrold J. Rust Jul 16, 2021 to Feb 7, 202317
- Chief financial officerRyan A. Benton Apr 17, 2025 to now18
- Chief financial officerFarhan Ahmad Jul 12, 2023 to Dec 12, 202419
- Chief financial officerSteffen Pietzke Jul 16, 2021 to Jul 7, 202320
- Chief financial officerEmmanuel T. Hernandez Dec 1, 2020 to Dec 1, 202021
- Chief operating officerMichael Vyvoda Aug 10, 2026 to now22
- Chief operating officerAjay Marathe Nov 16, 2022 to Aug 10, 202623
Board members and other officers (21)
- Chief Accounting OfficerKristina Truong Jan 17, 2025 to now24
- Chief Commercial OfficerRalph H. Schmitt Feb 8, 2023 to Aug 11, 202325
- OfficerArthi Chakravarthy May 2, 2023 to Apr 25, 202426
- Chief Technology OfficerAshok Lahiri Jul 16, 2021 to Feb 7, 202327
- OfficerEdward J. Hejlek Jul 16, 2021 to Nov 8, 202228
- Chief Commercial OfficerGardner Cameron Dales Jul 16, 2021 to Feb 7, 202329
- Board memberRajendra K. Talluri Jan 20, 2023 to now16
- Board memberBernard Gutmann Jun 27, 2023 to now30
- Board memberBetsy S. Atkins Jul 16, 2021 to now31
- Board memberGregory Reichow Jul 16, 2021 to now32
- Board memberHarrold J. Rust Jul 16, 2021 to Feb 7, 202317
- Board memberJ. Daniel McCranie Jul 16, 2021 to now33
- Board memberMichael A. Petrick Jul 16, 2021 to Oct 22, 202134
- Board memberThurman J. Rodgers Jul 16, 2021 to now35
- Board memberPegah Ebrahimi Nov 5, 2021 to now36
- Board memberEmmanuel T. Hernandez Dec 1, 2020 to Jun 20, 202321
- Board memberJohn Daniel McCranie Dec 1, 2020 to Dec 1, 202037
- Board memberJoseph Ian Malchow Dec 1, 2020 to now38
- Board memberLisan Hung Dec 1, 2020 to Dec 1, 202039
- Board memberSteven J. Gomo Dec 1, 2020 to Dec 1, 202040
- General counselArthi Chakravarthy May 9, 2024 to now41
Products and brands
- battery
Listed on Wikidata.1
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- Enovix Battery (Shenzhen) Co., Ltd. China6
- Enovix India Holdco LLC Delaware6
- Enovix International Holdco LLC Delaware6
- Enovix Malaysia Private Limited Malaysia6
- Enovix Research and Development Services India Private Limited India6
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
- Rodgers Silicon Valley Acquisition CorpOct 14, 2020 to Jul 14, 20215
Timeline
- Oct 13, 20268-K Results of operations; Regulation FD disclosure42
- Sep 1, 2026New chief executive Ryan A. Benton becomes CEO15
- Aug 17, 20268-K Executive or director change; Regulation FD disclosure43
- Aug 12, 20268-K Results of operations44
- Jul 9, 20268-K Executive or director change45
- Jun 12, 20268-K Shareholder vote46
- May 13, 20268-K Results of operations47
- May 5, 20268-K Regulation FD disclosure48
- Feb 25, 20268-K Results of operations49
- Jan 20, 20268-K Results of operations; Executive or director change; Regulation FD disclosure50
- Nov 5, 20258-K Results of operations51
- Sep 15, 20258-K Entered a material agreement; New debt or obligation; Unregistered sale of shares52
- Sep 9, 20258-K Regulation FD disclosure53
- Jan 20, 2023New chief executive Rajendra K. Talluri becomes CEO16
- Jul 16, 2021New chief executive Harrold J. Rust becomes CEO17
- 2021Went public Listed on NASDAQ1
- Sep 23, 2020Founded Enovix Corporation is founded3
Calendar
Coming up
- Nov 4, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported ($0.20) a share, on Nov 5, 2025.54
When it reported results
- Oct 13, 2026Reported quarterly or annual results42
- Aug 12, 2026Reported quarterly or annual results44
- May 13, 2026Reported quarterly or annual results47
- Feb 25, 2026Reported quarterly or annual results49
- Jan 20, 2026Reported quarterly or annual results50
- Nov 5, 2025Reported quarterly or annual results51
- Jul 31, 2025Reported quarterly or annual results55
- Jul 7, 2025Reported quarterly or annual results56
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
710 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 69 major events, 525 insider forms, 14 large holders, 81 other. The latest 20:
- Oct 13, 20264 EDGAR
- Oct 13, 20264 EDGAR
- Oct 13, 20268-K EDGAR
- Oct 7, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Sep 28, 20264 EDGAR
- Sep 14, 20264 EDGAR
- Sep 10, 20264 EDGAR
- Sep 1, 20264 EDGAR
- Sep 1, 20264 EDGAR
- Sep 1, 20264 EDGAR
- Aug 26, 20264 EDGAR
- Aug 17, 20264 EDGAR
- Aug 17, 20268-K CURRENT REPORT EDGAR
- Aug 12, 202610-Q EDGAR
- Aug 12, 20268-K EDGAR
- Aug 11, 20264 EDGAR
- Aug 11, 20264 EDGAR
The 710 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
51 open-market trades by officers, directors and large owners since October 2021: 16 buys and 35 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jan 1, 2026 | Truong KristinaChief Accounting Officer | Sale | 2,296 | $7.31 | $16.8K | Form 4 |
| Oct 8, 2025 | Marathe AjayFormer Chief Operating Officer | Sale | 18,614 | $13.00 | $242.0K | Form 4 |
| Oct 2, 2025 | Marathe AjayFormer Chief Operating Officer | Sale | 120,000 | $12.01 | $1.4M | Form 4 |
| May 2, 2025 | Reichow GregoryDirector | Sale | 8,129 | $6.57 | $53.4K | Form 4 |
| Feb 27, 2025 | Talluri Rajendra KPresident and CEO | Sale | 300,000 | $9.35 | $2.8M | Form 4 |
| Dec 3, 2024 | ATKINS BETSY SDirector | Sale | 75,000 | $9.73 | $729.8K | Form 4 |
| Oct 14, 2024 | Chakravarthy ArthiChief Legal Officer | Sale | 35,000 | $13.00 | $455.0K | Form 4 |
| Jun 20, 2024 | Reichow GregoryDirector | Sale | 7,500 | $12.14 | $91.0K | Form 4 |
| Apr 14, 2024 | Marathe AjayFormer Chief Operating Officer | Sale | 4,954 | $7.31 | $36.2K | Form 4 |
| Aug 24, 2023 | Talluri Rajendra KPresident and CEO | Buy | 1,434 | $13.94 | $20.0K | Form 4 |
| Aug 11, 2023 | ATKINS BETSY SDirector | Sale | 36,000 | $16.25 | $585.0K | Form 4 |
| Jun 20, 2023 | ATKINS BETSY SDirector | Sale | 4,528 | $15.02 | $68.0K | Form 4 |
| Apr 27, 2023 | Talluri Rajendra KPresident and CEO | Buy | 5,000 | $10.10 | $50.5K | Form 4 |
| Apr 24, 2023 | ATKINS BETSY SDirector | Sale | 5,000 | $12.36 | $61.8K | Form 4 |
| Mar 21, 2023 | Rodgers Thurman JDirector | Buy | 102,599 | $11.57 | $1.2M | Form 4 |
| Mar 20, 2023 | Rodgers Thurman JDirector | Buy | 69,557 | $10.88 | $756.8K | Form 4 |
| Mar 17, 2023 | Rodgers Thurman JDirector | Buy | 98,700 | $10.95 | $1.1M | Form 4 |
| Mar 16, 2023 | Rodgers Thurman JDirector | Buy | 34,899 | $10.96 | $382.5K | Form 4 |
| Mar 15, 2023 | Rodgers Thurman JDirector | Buy | 129,111 | $10.47 | $1.4M | Form 4 |
| Mar 14, 2023 | Talluri Rajendra KPresident and CEO | Buy | 5,000 | $11.22 | $56.1K | Form 4 |
All 51 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- BlackRockSCHEDULE 13G/A, 2 filings Jan 29, 2024 to Jul 28, 202657
- VANGUARD GROUP INCSCHEDULE 13G/A, 3 filings Feb 9, 2023 to Mar 26, 202658
- Thurman J. RodgersSCHEDULE 13D/A, 2 filings Feb 14, 2023 to Jul 22, 202559
- Park West Asset Management LLCSC 13G/A, 2 filings Feb 14, 2023 to Feb 14, 202460
- Eclipse GP III, LLCSC 13G/A, 1 filing Jan 25, 202361
- York Capital Management Global Advisors, LLCSC 13G/A, 2 filings Feb 14, 2022 to Mar 23, 202262
- GILDER GAGNON HOWE & CO LLCSC 13G/A, 1 filing Feb 14, 202263
- Electron Capital Partners, LLCSC 13G/A, 1 filing Jan 11, 202264
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Dr. Raj TalluriPresident and Chief Executive Officer | 63 | $617.5K | $8.0M65 |
| 2025 | Ryan BentonChief Financial Officer | 55 | $301.0K | $4.9M65 |
| 2025 | Ajay MaratheFormer Chief Operating Officer | 64 | $473.9K | $4.7M65 |
| 2025 | Arthi ChakravarthyChief Legal Officer | 47 | $365.3K | $2.0M65 |
| 2024 | Dr. Raj TalluriPresident and Chief Executive Officer | 63 | $595.0K | $11.5M65 |
| 2024 | Ajay MaratheFormer Chief Operating Officer | 64 | $463.5K | $4.2M65 |
| 2024 | Arthi ChakravarthyChief Legal Officer | 47 | $357.3K | $3.0M65 |
| 2023 | Ajay MaratheFormer Chief Operating Officer | 64 | $450.0K | $585.2K65 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 16,483,412 | $100.1M | 0.0% | +1,152,623 |
| Vanguard Capital Management LLC | 8,494,145 | $51.6M | 0.0% | +114,907 |
| Vanguard Portfolio Management LLC | 8,374,109 | $50.8M | 0.0% | +322,911 |
| UBS Group AG | 5,305,746 | $32.2M | 0.0% | −464,325 |
| Geode Capital Management, LLC | 5,184,598 | $31.5M | 0.0% | +312,508 |
| Electron Capital Partners, LLC | 4,788,098 | $29.1M | 1.2% | +159,781 |
| State Street Corp | 4,720,841 | $28.7M | 0.0% | +404,052 |
| Morgan Stanley | 3,470,634 | $21.1M | 0.0% | +1,658,688 |
| Royal Bank Of Canada | 2,504,811 | $15.2M | 0.0% | +12,557 |
| Fred Alger Management, LLC | 2,097,840 | $12.7M | 0.0% | +125,245 |
| Susquehanna International Group, Llp | 2,097,625 | $12.7M | 0.0% | +284,045 |
| CenterBook Partners LP | 2,041,919 | $12.4M | 0.6% | −899,048 |
| Masters Capital Management LLC | 2,000,000 | $12.1M | 1.7% | No change |
| Northern Trust Corp | 1,698,246 | $10.3M | 0.0% | +136,076 |
| Goldman Sachs Group Inc | 1,670,802 | $10.1M | 0.0% | +308,845 |
| Tudor Investment Corp Et Al | 1,667,130 | $10.1M | 0.0% | +443,243 |
| Charles Schwab Investment Management Inc | 1,649,175 | $10.0M | 0.0% | +286,168 |
| Citadel Advisors LLC | 1,591,905 | $9.7M | 0.0% | +806,576 |
| Connor, Clark & Lunn Investment Management Ltd. | 1,431,475 | $8.7M | 0.0% | +139,702 |
| Bank Of America Corp /de/ | 1,376,635 | $8.4M | 0.0% | +641,683 |
| Vanguard Fiduciary Trust Co | 1,367,678 | $8.3M | 0.0% | +24,110 |
| Marshall Wace, Llp | 1,319,796 | $8.0M | 0.0% | +1,223,908 |
| Invesco Ltd. | 1,218,392 | $7.4M | 0.0% | −281,820 |
| Toronto Dominion Bank | 1,198,919 | $7.3M | 0.0% | +14,101 |
| Barclays PLC | 1,073,806 | $6.5M | 0.0% | +153,170 |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
1 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Jan 31, 2023 | Daniel S. GoldmanDemocratic, House | Sale | $1,001 - $15,000 | +158.5% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
SEC filer profile
How Enovix Corporation is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGAREnovix Corp2
- CIK0001828318
- Employer ID (EIN)85-31743577
- Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company7
- Incorporated inDelaware7
- Fiscal year endsDecember 282
- Industry code (SIC)3690 Miscellaneous Electrical Machinery, Equipment & Supplies2
- SEC reviewing officeOffice of Manufacturing, Division of Corporation Finance2
- Business address3501 W. Warren Avenue, Fremont, CA 945382
- Phone510 695-23502
- Shares outstanding219,448,535 as of Aug 7, 202612
- Public float$1.6B as of Jun 27, 20257
- AuditorDELOITTE & TOUCHE LLP, San Jose, California PCAOB ID 34; it also attests to the company’s internal control over financial reporting7
- On EDGAR sinceOct 14, 20202
- Filings815 in all: 4 (520), 8-K (79), 3 (32), 424B3 (22), 10-Q (17), CORRESP (12), DEFA14A (12), 144 (11)2
All 43 form types
SC 13G/A (10), 4/A (9), UPLOAD (9), SC 13G (8), EFFECT (7), 10-K (6), S-8 (6), 425 (5), DEF 14A (5), ARS (4), 25-NSE (3), 424B5 (3), S-4/A (3), 10-K/A (2), 3/A (2), 8-A12B (2), CERT (2), POS AM (2), S-1 (2), S-1/A (2), S-3 (2), SC 13D/A (2), SCHEDULE 13G/A (2), 424B2 (1), 424B4 (1), 424B7 (1), 8-A12B/A (1), 8-K/A (1), DRS (1), NT 10-Q (1), S-3/A (1), S-3ASR (1), S-4 (1), SC 13D (1), SCHEDULE 13D/A (1)
- Latest filingsAnnual report (10-K) Feb 25, 2026
Quarterly report (10-Q) Aug 12, 2026
Proxy statement (DEF 14A) Apr 24, 2026
Latest 8-K (8-K) Oct 13, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, par value $0.0001 per share | ENVX | The Nasdaq Global Select Market |
From the cover page of the 10-K filed Feb 25, 2026 (Section 12(b) of the Exchange Act).7
Risk factors and legal proceedings
The risks Enovix Corporation names in Item 1A of its 10-K filed Feb 25, 2026: 66 risks under these headings, as written.7
- You should not interpret our disclosure of any of the following risks to imply that such risks have not already materialized.
- Risks Related to Our Manufacturing and Scale-Up
- We will need to improve our energy density, cycle life, fast charging, capacity roll off and gassing metrics in order to stay ahead of competition over time, which is difficult, and we may not be able to do.
- We rely on a new and complex manufacturing process for our operations, and achieving volume production involves a significant degree of risk and uncertainty in terms of operational performance such as yield and costs.
- If we cannot successfully scale our manufacturing facilities to produce our lithium-ion battery cell in sufficient quantities to meet expected demand, improve productivity and bring additional facilities online, we may be unable to achieve our profitability targets, and our business will be negatively impacted and could fail.
- We may be unable to adequately control the costs associated with our operations and the components necessary to build our lithium-ion battery cells.
- We rely on a manufacturing agreement with a Malaysia-based company for some of the facilities, procurement, and personnel needs of our operations. Changes to our relationship with such third-party contract manufacturer, expected or unexpected, may result in delays or disruptions that could harm our business.
- Our operations in international markets, including our manufacturing operations, expose us to operational, financial and regulatory risks, as well as risks relating to geopolitical tensions and conflicts, including changes to trade policies and regulations.
- Changes in global trade policies, tariffs, export controls and other cross-border restrictions could materially adversely affect our revenues, operating results and ability to source materials and equipment.
- We rely on third-party suppliers for critical components and equipment, and disruptions in these relationships could delay production and harm our business, results of operations, financial condition and cash flows.
- Increases in raw material costs and supply disruptions resulting from global market and geopolitical conditions could increase our product costs and adversely affect our business and results of operations.
- Risks Related to Our Customers
The other 56 risks
- Lengthy sales cycles, unpredictable safety risks and certain provisions of defense and other customer contracts may negatively impact our ability to maintain and grow our customer base, which could adversely affect our business and future prospects.
- If our batteries fail to perform as expected, our ability to develop, market and sell our batteries could be harmed.
- We have significant customer concentration in key market sectors and dependence on these customers creates a risk to our business and financial condition.
- Our future growth and success depend on our ability to qualify new customers and the customer qualification cycles can take years to complete.
- Our future growth and success depend on our ability to sell effectively to, and manage relationships with large enterprise and defense customers.
- We may not be able to accurately estimate the future supply and demand for our batteries, which could result in a variety of inefficiencies in our business and hinder our ability to generate revenue. If we fail to accurately predict our manufacturing requirements, we could incur additional costs or experience delays.
- Increases in sales of our lithium-ion battery cells may expose us to the risks associated with manufacturing batteries for unique customer specifications and increase our dependency upon specific customers, including due to the costs to develop and qualify our system solutions.
- Risks Related to Our Business
- We have a history of financial losses and expect to incur significant expenses and continuing losses for the foreseeable future.
- If we are unable to develop our business and effectively commercialize our products as anticipated, we may not be able to generate revenue or achieve profitability.
- We face significant barriers in our attempts to produce our products, our products are still under development, and we may not be able to successfully develop our products at commercial scale. If we cannot successfully overcome those barriers, our business will be negatively impacted and could fail.
- We have acquired and may continue to acquire other businesses, which could require significant management attention, disrupt our business, and dilute stockholder value.
- Fluctuations in foreign currency exchange rates and interest rates have had, and could continue to have, an adverse impact on our financial condition and results of operations.
- Operational problems with our manufacturing equipment subject us to safety risks which, if not adequately addressed, could have a material adverse effect on our business, results of operations, cash flows, financial condition or prospects.
- Lithium-ion battery modules in the marketplace have been observed to catch fire or vent smoke and flame, and such events have raised concerns over the use of such batteries.
- The battery market continues to evolve and is highly competitive, and we may not be successful in competing in this industry or establishing and maintaining confidence in our long-term business prospects among current and future partners and customers.
- We could face state-sponsored competition from overseas and may not be able to compete in the market on the basis of price.
- Our failure to keep up with rapid technological changes and evolving industry standards may cause our batteries to become less marketable or obsolete, resulting in a decrease in demand for our batteries and harm our ability to grow revenue and expand margins.
- We may become subject to product liability claims, which could harm our financial condition and liquidity if we are not able to successfully defend or insure against such claims.
- If we are unable to attract and retain key employees and qualified personnel on a global basis, our business and prospects could be harmed.
- If we are unable to maintain effective internal control over financial reporting in the future, or implement or integrate effective internal control over financial reporting with respect to any acquired entities or subsidiaries, investors may lose confidence in the accuracy and completeness of our financial reports, and the market price of our common stock may be materially adversely affected.
- We have incurred and will continue to incur significant increased expenses and administrative burdens as a public company, which could negatively impact our business, financial condition and results of operations.
- We have previously been, currently are, and may in the future be involved in class-action lawsuits and other litigation matters, including commercial and other contractual disputes, that are expensive and time-consuming. If resolved adversely, lawsuits and other litigation matters could seriously harm our business.
- Risks Related to Our Capital Needs and Capital Strategy
- We may not have adequate funds to finance our operating needs and our growth, and may need to raise additional capital, which we may not be able to do.
- Raising additional funds may cause dilution to existing stockholders and/or may restrict our operations or require us to relinquish proprietary rights.
- Risks Related to Our Convertible Senior Notes
- Servicing our debt requires a significant amount of cash, and we may not have sufficient cash flow from our business to pay our substantial debt.
- The conditional conversion feature of the Convertible Senior Notes, if triggered, may adversely affect our financial condition and operating results.
- Certain provisions in the indenture governing the Convertible Senior Notes may delay or prevent an otherwise beneficial takeover attempt of us.
- Conversion of the Convertible Senior Notes may dilute the ownership interest of our stockholders or may otherwise depress the price of our common stock.
- The accounting method for the Convertible Senior Notes could adversely affect our reported financial condition and results.
- The capped call transactions may affect the value of the Convertible Senior Notes and our common stock.
- We are subject to counterparty risk with respect to the Capped Call Transactions.
- Risks Related to Our Intellectual Property
- We rely heavily on our intellectual property portfolio. If we are unable to protect our intellectual property rights, our business and competitive position would be harmed.
- We may need to defend ourselves against intellectual property infringement claims, which may be time-consuming and could cause us to incur substantial costs.
- Our patent applications may not result in issued patents or our patent rights may be contested, circumvented, invalidated or limited in scope, any of which could have a material adverse effect on our ability to prevent others from interfering with our commercialization of our products.
- Risks Related to Our Regulatory Compliance
- We may encounter regulatory approval difficulties which could delay our ability to launch our lithium-ion battery cells, and compliance with regulatory laws may limit their usefulness.
- We are subject to substantial regulation, and unfavorable changes to, or our failure to comply with, these regulations could substantially harm our business and operating results.
- We are subject to a variety of laws and regulations related to the safety and transportation of our batteries. Our failure to comply with these laws and regulations may have a material adverse effect on our business and results of operations.
- We are subject to requirements relating to environmental and safety regulations and environmental remediation matters which could adversely affect our business, results of operations and reputation.
- We have expended significant resources as a public company to comply with Section 404(a)of the Sarbanes-Oxley Act of 2002, which compliance costs may increase as our operations expand. Any failure to maintain effective controls and procedures could negatively impact our business.
- Risks Related to Ownership of Our Securities
- The trading price of our common stock may be volatile, and the value of our common stock may decline.
- If securities or industry analysts do not publish or cease publishing research or reports about us, our business, or our market, or if they change their recommendations regarding our securities adversely, the price and trading volume of our securities could decline.
- The future sales of shares by existing stockholders may adversely affect the market price of our common stock.
- Private Placement Warrants are exercisable for our common stock, which would increase the number of shares eligible for future resale in the public market and result in dilution to our stockholders.
- An active trading market for our securities may not continue, which would adversely affect the liquidity and price of our securities.
- There can be no assurance that we will be able to comply with the continued listing standards of the Nasdaq Global Select Market.
- Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware and U.S. federal district courts will be the exclusive forums for certain disputes between us and our stockholders, which could limit our stockholders’ ability to choose the judicial forum for disputes with us or our directors, officers or employees.
- General Risk Factors
- Global conflicts could adversely impact our business, costs, supply chain, sales, financial condition or results of operations.
- If our batteries, our website, systems or data we maintain are or were compromised we could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; loss of customers or sales; and other adverse consequences.
- We are subject to stringent and evolving U.S. and foreign laws and other obligations related to data privacy and security. Our actual or perceived failure to comply with such obligations could harm our reputation and expose us to increased liability and other adverse business consequences.
- We are exposed to risks related to the use of AI by us and others in our industry.
- Our facilities or operations could be damaged or adversely affected as a result of natural disasters and other catastrophic events.
- Any financial or economic crisis, or perceived threat of such a crisis, including a significant decrease in consumer confidence, may materially and adversely affect our business, financial condition and results of operations.
- Our ability to utilize our net operating losses and certain other tax attributes to offset future taxable income and taxes may be subject to certain limitations.
- Changes in tax laws or regulations that are applied adversely to us or our customers may have a material adverse effect on our business, cash flow, financial condition or results of operations.
- We are subject to anti-corruption, anti-bribery, anti-money laundering, import and export controls, financial and economic sanctions and similar laws, and non-compliance with such laws can subject us to administrative, civil and criminal fines and penalties, collateral consequences, remedial measures and legal expenses, all of which could adversely affect our business, results of operations, financial condition and reputation.
- Our insurance coverage may not be adequate to protect us from all business risks.
Legal proceedings
The information included under the heading “Litigation” in Note 10 “Commitments and Contingencies” of our Consolidated Financial Statements in this Annual Report is incorporated herein by reference.
The opening of Item 3, Legal Proceedings.7
Links
- Websitewww.enovix.com1
- X (Twitter)x.com/EnovixBatteries1
- LinkedInwww.linkedin.com/company/enovix-corp-1
- WikidataQ124624329
- SEC EDGARCIK 1828318
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataEnovix Corporation on Wikidata
- 2
- 3
- 4Company websiteEnovix Corporation logo
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26SEC EDGARArthi Chakravarthy, Officer
- 27
- 28SEC EDGAREdward J. Hejlek, Officer
- 29
- 30SEC EDGARBernard Gutmann, Board member
- 31SEC EDGARBetsy S. Atkins, Board member
- 32SEC EDGARGregory Reichow, Board member
- 33SEC EDGARJ. Daniel McCranie, Board member
- 34SEC EDGARMichael A. Petrick, Board member
- 35SEC EDGARThurman J. Rodgers, Board member
- 36SEC EDGARPegah Ebrahimi, Board member
- 37SEC EDGARJohn Daniel McCranie, Board member
- 38SEC EDGARJoseph Ian Malchow, Board member
- 39SEC EDGARLisan Hung, Board member
- 40SEC EDGARSteven J. Gomo, Board member
- 41SEC EDGARArthi Chakravarthy, General counsel
- 42
- 43
- 44SEC EDGARResults of operations
- 45SEC EDGARExecutive or director change
- 46SEC EDGARShareholder vote
- 47SEC EDGARResults of operations
- 48SEC EDGARRegulation FD disclosure
- 49SEC EDGARResults of operations
- 50
- 51SEC EDGARResults of operations
- 52
- 53SEC EDGARRegulation FD disclosure
- 54NasdaqNasdaq calendar
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65